JPMorgan Chase & Co’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
66,675
+35,439
| +113% | +$181K | ﹤0.01% | 4224 |
|
|
2025
Q1 | $42.8K | Sell |
31,236
-77
| -0.2% | -$105 | ﹤0.01% | 5084 |
|
|
2024
Q4 | $96.8K | Sell |
31,313
-21,527
| -41% | -$66.5K | ﹤0.01% | 4791 |
|
|
2024
Q3 | $407K | Buy |
52,840
+1,281
| +2% | +$9.86K | ﹤0.01% | 4139 |
|
|
2024
Q2 | $442K | Sell |
51,559
-71,138
| -58% | -$610K | ﹤0.01% | 3915 |
|
|
2024
Q1 | $974K | Buy |
122,697
+72,894
| +146% | +$579K | ﹤0.01% | 3590 |
|
|
2023
Q4 | $493K | Buy |
49,803
+2,551
| +5% | +$25.3K | ﹤0.01% | 3920 |
|
|
2023
Q3 | $532K | Buy |
47,252
+7,624
| +19% | +$85.8K | ﹤0.01% | 3695 |
|
|
2023
Q2 | $132K | Sell |
39,628
-21,341
| -35% | -$70.9K | ﹤0.01% | 4509 |
|
|
2023
Q1 | $241K | Buy |
60,969
+10,980
| +22% | +$43.4K | ﹤0.01% | 4226 |
|
|
2022
Q4 | $363K | Buy |
49,989
+8,134
| +19% | +$59.1K | ﹤0.01% | 3923 |
|
|
2022
Q3 | $151K | Sell |
41,855
-7,472
| -15% | -$27K | ﹤0.01% | 4283 |
|
|
2022
Q2 | $224K | Buy |
49,327
+23,090
| +88% | +$105K | ﹤0.01% | 4270 |
|
|
2022
Q1 | $199K | Sell |
26,237
-6,298
| -19% | -$47.8K | ﹤0.01% | 4452 |
|
|
2021
Q4 | $357K | Buy |
32,535
+30,723
| +1,696% | +$337K | ﹤0.01% | 4239 |
|
|
2021
Q3 | $23K | Buy |
+1,812
| New | +$23K | ﹤0.01% | 5113 |
|
|
2020
Q4 | – | Sell |
-100,000
| Closed | -$1.02M | – | 5093 |
|
|
2020
Q3 | $1.02M | Buy |
+100,000
| New | +$1.02M | ﹤0.01% | 3086 |
|